Naloxone-precipitated withdrawal in morphine-dependent rats increases the expression of α(2a)-adrenoceptor mRNA in brain

Molecular Brain Research

Volumn 45, Issue 1, 1997, Pages 154-158

  Busquets, Xavier ^a   Ventayol, Pere ^a   García Sevilla, Jesús A ^a  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

Author keywords

Morphine abstinence syndrome; Morphine dependence; Northern and dot blot analyses; Opiate addiction; Rat brain; (2a) adrenoceptor mRNA

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR 2A; MESSENGER RNA; NALOXONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; GENE EXPRESSION; MORPHINE ADDICTION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031127496     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(96)00307-5     Document Type: Article

References (25)

1. [1] Aghajanian, G.K., Tolerance of locus coeruleus neurones to morphine and supression of withdrawal response by clonidine, Nature (London), 276 (1978) 186-188.
2. [2] Bergsbaken, C.L., Sommers, S.L. and Law, P.Y., Effect of forskolin and isobutylmethylxanthine on delta-opioid receptor activity in neuroblastoma × glioma NG 108-15 cells, J. Pharmacol. Exp. Ther., 264 (1993) 1474-1483.
3. [3] Busquets, X., Escribá, P.V., Sastre, M. and García-Sevilla, J.A., Loss of protein kinase C-αβ in brain of heroin addicts and morphine-dependent rats, J. Neurochem., 64 (1995) 247-252.
4. [4] Bylund, D.B., Eikenberg, D.C., Hieble, J.P., Langer, S.Z., Lefkowitz, R.J., Minneman, K.P., Molinoff, P.B., Ruffolo, R.R. and Trendelenburg, U., IV International Union of Pharmacology Nomenclature of Adrenoceptors, Pharmacol. Rev., 46 (1994) 121-136.
5. [5] Charney, D.S., Redmond, D.E.J., Galloway, M.D., Kleber, H.D., Heninger, G.R., Murberg, M. and Roth, R.H., Naltrexone-precipitated opiate withdrawal in methadone addicted human subjects: evidence for noradrenergic hyperactivity, Life Sci., 35 (1984) 1263-1272.
6. [6] Chomczynski, P. and Sacchi, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal. Biochem., 162 (1987) 156-159.
7. [7] Done, C., Silverstone, P. and Sharp, T., Effect of naloxone-precipitated morphine withdrawal on noradrenaline release in rat hippocampus in vivo, Eur. J. Pharmacol., 215 (1992) 333-336.
8. [8] Escribá, P.V., Sastre, M. and García-Sevilla, J.A., Increased density of guanine nucleotide-binding proteins in the postmortem brains of heroin addicts, Arch. Gen. Psychiatry, 51 (1994) 494-501.
9. 2-adrenoceptors in the rat brain: up-regulation of receptors associated with increased receptor appearance, J. Neurochem., 64 (1995) 2590-2597.
10. 2-adrenoceptors in heroin addicts during withdrawal and after treatment with clonidine, Eur. J. Pharmacol., 114 (1985) 365-374.
11. 2-adrenoceptors in the rat brain, Br. J. Pharmacol., 89 (1986) 516P.
12. 2-Adrenoceptor-mediated inhibition of platelet adenylate cyclase activity in heroin addicts in abstinence, Psychopharmacology, 92 (1987) 320-323.
13. 2-adrenergic receptor, Science, 238 (1987) 650-656.
14. 2A-adrenergic receptor confer short term agonist-promoted desensitization, J. Biol. Chem., 267 (1992) 4740-4746.
15. 2-receptor classification, Mol. Pharmacol., 58 (1990) 599-603.
16. [16] Montminy, M.R., González, G.A. and Yamamoto, K.K., Regulation of cAMP-inducible genes by CREB, Trends Neurosci., 13 (1990) 184-188.
17. [17] Nestler, E.J., Molecular mechanism of drug addiction, J. Neurosci., 12 (1992) 2439-2450.
18. [18] Nicholas, P., Hökfelt, T. and Pieribone, V.A., The distribution and significance of CNS adrenoceptors examined with in situ hybridization, Trends Pharmacol. Sci., 17 (1996) 245-255.
19. 2A-adrenergic receptor gene in HT-29 cells, J. Biol. Chem., 266 (1991) 5743-5749.
20. [20] Sambrook, J., Fritsch, E.F. and Maniatis, T., Molecular cloning. A Laboratory Manual, Vol. 1, 2nd Ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989.
21. 2A-adrenergic receptor gene by cAMP: evidence for multiple cAMP responsive sequences in the promoter region of this gene, Cell. Signal., 6 (1994) 73-82.
22. 2-adrenoceptor number and function in brains of morphine-dependent rats, Eur. J. Pharmacol, 161 (1989) 111-119.
23. [23] Swann, A.C., Elsworth, J.D., Charney, D.S., Jablons, D.M., Roth, R.H., Redmond, D.E.J. and Maas, J,W., Brain catecholamine metabolites and behaviour in morphine withdrawal, Eur. J. Pharmacol., 86 (1983) 167-175.
24. [24] Thilo, J.B. and Burnet, W.J., The role of adenylate cyclase in neuropsychiatric disease, Psychopharmacol. Bull., 28 (1992) 477-500.
25. 2-adrenoceptor and μ-opioid receptor densities during morphine dependence and spontaneous withdrawal in rats, Naunyn-Schmiedeberg's Arch. Pharmacol. 336 (1987) 530-537.